The long-term objective of the work supported by this grant is to define the role of Epstein-Barr virus (EBV) in Burkitt lymphoma (BL), a B-cell tumor that occurs in geographically distinct regions, and which is also associated with immunosuppression as a consequence of HIV infection and AIDS. The underlying hypothesis of this grant is that EBV contributes directly to BL, despite lack of expression of the known viral transforming genes within the tumor cells. This is supported by the observation that the tumorigenic potential of the BL cell line Akata is dependent on EBV infection and at least two viral gene products the EBV small RNAs EBER-1 and EBER-2. The contribution of the EBER RNAs to tumorigenic potential, however, is partial relative to that conferred by EBV infection as a whole, indicating that additional viral genes expressed during infection of BL cells are important. The immediate goals of the proposed work are to define the mechanistic contributions of the EBER RNAs and other EBV gene products to the tumorigenic potential of BL cells and to lymphomagenesis itself.
Three specific aims are proposed.
Under Aim 1, we will identify the cellular targets of the EBER RNAs and define the mechanisms through which they are regulated. We will address two potential mechanisms of EBER function that are suggested by previous experimental observations. The first is that the EBER RNAs function in posttranscriptional gene silencing through direct RNA:RNA interactions with cellular gene RNAs. The second, based on known interactions of the EBERs with components of the cellular translational machinery, is that the EBERs regulate translation of specific cellular mRNAs.
Under Aim 2, we will define the contributions of proteins encoded by the EBV BamHI rightward transcripts (BARTs) to BL-cell tumorigenic potential, and in particular whether any of these proteins are responsible for the enhanced survival conferred upon BL cells by EBV that is attributed to viral-enforced down-regulation of the c-MYC proto-oncoprotein under growth-limiting conditions.
Under Aim 3, we will assess the importance of EBV genes expressed in BL cell lines to actual lymphomagenesis using the murine model of BL, the Emu-myc transgenic mouse, in which expression of the c-myc proto-oncogene, as in BL, is constitutively overexpressed in B lymphocytes. Specifically, we will express the EBV genes within the B cells of these mice to determine whether this accelerates c-Myc-induced lymphomagenesis, and if so, we will identify the genetic and biochemical basis for this contribution to lymphoma.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA073544-08
Application #
6878493
Study Section
Special Emphasis Panel (ZRG1-AARR-1 (14))
Program Officer
Daschner, Phillip J
Project Start
1996-09-30
Project End
2008-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
8
Fiscal Year
2005
Total Cost
$282,000
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Hughes, David J; Marendy, Elessa M; Dickerson, Carol A et al. (2012) Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency. J Virol 86:1034-45
Hughes, David J; Dickerson, Carol A; Shaner, Marie S et al. (2011) trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency. J Virol 85:11435-47
Ruf, Ingrid K; Houmani, Jennifer L; Sample, Jeffery T (2009) Epstein-Barr virus independent dysregulation of UBP43 expression alters interferon-stimulated gene expression in Burkitt lymphoma. PLoS One 4:e6023
Yoshioka, Mikio; Crum, Michelle M; Sample, Jeffery T (2008) Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing. J Virol 82:1679-87
Garrison, Sean P; Jeffers, John R; Yang, Chunying et al. (2008) Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol 28:5391-402
Han, Zhao; Marendy, Elessa; Wang, Yong-Dong et al. (2007) Multiple roles of Epstein-Barr virus SM protein in lytic replication. J Virol 81:4058-69
Ruf, Ingrid K; Lackey, Kristen A; Warudkar, Swati et al. (2005) Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR. J Virol 79:14562-9
Ruf, I K; Rhyne, P W; Yang, H et al. (2001) EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma. Curr Top Microbiol Immunol 258:153-60
Ruf, I K; Rhyne, P W; Yang, C et al. (2000) Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J Virol 74:10223-8
Swart, R; Ruf, I K; Sample, J et al. (2000) Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway. J Virol 74:10838-45

Showing the most recent 10 out of 13 publications